Congenital Absence of the Portal Vein as a Rare Cause of Portopulmonary Hypertension—A Case Study Series

<i>Background</i>. Congenital absence of the portal vein (CAPV) is an extremely rare malformation that is caused by aberrant venous development during embryogenesis and is usually associated with congenital portosystemic shunts (CPSS). This hemodynamic allows mesenteric blood to bypass t...

Full description

Bibliographic Details
Main Authors: Tereza Hlavata, Monika Kaldararova, Filip Klauco, Erika Drangova, Adriana Reptova, Iveta Simkova
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Medicina
Subjects:
Online Access:https://www.mdpi.com/1648-9144/58/10/1484
_version_ 1797471619970498560
author Tereza Hlavata
Monika Kaldararova
Filip Klauco
Erika Drangova
Adriana Reptova
Iveta Simkova
author_facet Tereza Hlavata
Monika Kaldararova
Filip Klauco
Erika Drangova
Adriana Reptova
Iveta Simkova
author_sort Tereza Hlavata
collection DOAJ
description <i>Background</i>. Congenital absence of the portal vein (CAPV) is an extremely rare malformation that is caused by aberrant venous development during embryogenesis and is usually associated with congenital portosystemic shunts (CPSS). This hemodynamic allows mesenteric blood to bypass the liver metabolism and causes an imbalance between vasodilators and vasoconstrictors in the pulmonary circulation, which, again, might lead to the development of secondary portopulmonary hypertension (PoPH). Establishing the exact morphology of the splanchnic venous system is important when evaluating possible therapeutic options (differentiating type I and II CAPV), because some variants enable the closure of the shunt, and this represents a potential cure for pulmonary arterial hypertension (PAH). Once PoPH is diagnosed, complex care in a specialized expert centre is necessary. If possible, CPSS closure is recommended. For long-term successful patient management, specific targeted PAH therapy administration is crucial. Significant morbidity and mortality in these patients may result not only from PAH itself but also due to specific PoPH complications, such as compression of the left main coronary artery by pulmonary artery aneurysm. <i>Case Report</i>. We report on two patients with PoPH due to CAPV and CPSS (without any liver disease) who presented as severe PAH and who, before admission to our expert centre, were misdiagnosed as idiopathic PAH. The case reports also represent our experience with respect to the long-term follow-up and PAH-specific medical treatment of these patients, as well as the possible (even fatal) complications of these rare and complex patients.
first_indexed 2024-03-09T19:50:34Z
format Article
id doaj.art-f98de39adece4761bbf01c13a111897d
institution Directory Open Access Journal
issn 1010-660X
1648-9144
language English
last_indexed 2024-03-09T19:50:34Z
publishDate 2022-10-01
publisher MDPI AG
record_format Article
series Medicina
spelling doaj.art-f98de39adece4761bbf01c13a111897d2023-11-24T01:12:02ZengMDPI AGMedicina1010-660X1648-91442022-10-015810148410.3390/medicina58101484Congenital Absence of the Portal Vein as a Rare Cause of Portopulmonary Hypertension—A Case Study SeriesTereza Hlavata0Monika Kaldararova1Filip Klauco2Erika Drangova3Adriana Reptova4Iveta Simkova5Department of Cardiology and Angiology, Adult Congenital Heart Disease Department, Medical Faculty, Slovak Medical University and The National Institute of Cardiovascular Diseases, Pod Krasnou Horkou 1, 833 48 Bratislava, SlovakiaDepartment of Cardiology and Angiology, Adult Congenital Heart Disease Department, Medical Faculty, Slovak Medical University and The National Institute of Cardiovascular Diseases, Pod Krasnou Horkou 1, 833 48 Bratislava, SlovakiaDepartment of Cardiology and Angiology, Adult Congenital Heart Disease Department, Medical Faculty, Slovak Medical University and The National Institute of Cardiovascular Diseases, Pod Krasnou Horkou 1, 833 48 Bratislava, SlovakiaDepartment of Diagnostic and Interventional Radiology, Medical Faculty, Slovak Medical University and The National Institute of Cardiovascular Diseases, Pod Krasnou Horkou 1, 833 48 Bratislava, SlovakiaDepartment of Cardiology and Angiology, Adult Congenital Heart Disease Department, Medical Faculty, Slovak Medical University and The National Institute of Cardiovascular Diseases, Pod Krasnou Horkou 1, 833 48 Bratislava, SlovakiaDepartment of Cardiology and Angiology, Adult Congenital Heart Disease Department, Medical Faculty, Slovak Medical University and The National Institute of Cardiovascular Diseases, Pod Krasnou Horkou 1, 833 48 Bratislava, Slovakia<i>Background</i>. Congenital absence of the portal vein (CAPV) is an extremely rare malformation that is caused by aberrant venous development during embryogenesis and is usually associated with congenital portosystemic shunts (CPSS). This hemodynamic allows mesenteric blood to bypass the liver metabolism and causes an imbalance between vasodilators and vasoconstrictors in the pulmonary circulation, which, again, might lead to the development of secondary portopulmonary hypertension (PoPH). Establishing the exact morphology of the splanchnic venous system is important when evaluating possible therapeutic options (differentiating type I and II CAPV), because some variants enable the closure of the shunt, and this represents a potential cure for pulmonary arterial hypertension (PAH). Once PoPH is diagnosed, complex care in a specialized expert centre is necessary. If possible, CPSS closure is recommended. For long-term successful patient management, specific targeted PAH therapy administration is crucial. Significant morbidity and mortality in these patients may result not only from PAH itself but also due to specific PoPH complications, such as compression of the left main coronary artery by pulmonary artery aneurysm. <i>Case Report</i>. We report on two patients with PoPH due to CAPV and CPSS (without any liver disease) who presented as severe PAH and who, before admission to our expert centre, were misdiagnosed as idiopathic PAH. The case reports also represent our experience with respect to the long-term follow-up and PAH-specific medical treatment of these patients, as well as the possible (even fatal) complications of these rare and complex patients.https://www.mdpi.com/1648-9144/58/10/1484congenital absence of the portal veincongenital portosystemic shuntpulmonary arterial hypertensionportopulmonary hypertensionspecific therapypulmonary artery aneurysm
spellingShingle Tereza Hlavata
Monika Kaldararova
Filip Klauco
Erika Drangova
Adriana Reptova
Iveta Simkova
Congenital Absence of the Portal Vein as a Rare Cause of Portopulmonary Hypertension—A Case Study Series
Medicina
congenital absence of the portal vein
congenital portosystemic shunt
pulmonary arterial hypertension
portopulmonary hypertension
specific therapy
pulmonary artery aneurysm
title Congenital Absence of the Portal Vein as a Rare Cause of Portopulmonary Hypertension—A Case Study Series
title_full Congenital Absence of the Portal Vein as a Rare Cause of Portopulmonary Hypertension—A Case Study Series
title_fullStr Congenital Absence of the Portal Vein as a Rare Cause of Portopulmonary Hypertension—A Case Study Series
title_full_unstemmed Congenital Absence of the Portal Vein as a Rare Cause of Portopulmonary Hypertension—A Case Study Series
title_short Congenital Absence of the Portal Vein as a Rare Cause of Portopulmonary Hypertension—A Case Study Series
title_sort congenital absence of the portal vein as a rare cause of portopulmonary hypertension a case study series
topic congenital absence of the portal vein
congenital portosystemic shunt
pulmonary arterial hypertension
portopulmonary hypertension
specific therapy
pulmonary artery aneurysm
url https://www.mdpi.com/1648-9144/58/10/1484
work_keys_str_mv AT terezahlavata congenitalabsenceoftheportalveinasararecauseofportopulmonaryhypertensionacasestudyseries
AT monikakaldararova congenitalabsenceoftheportalveinasararecauseofportopulmonaryhypertensionacasestudyseries
AT filipklauco congenitalabsenceoftheportalveinasararecauseofportopulmonaryhypertensionacasestudyseries
AT erikadrangova congenitalabsenceoftheportalveinasararecauseofportopulmonaryhypertensionacasestudyseries
AT adrianareptova congenitalabsenceoftheportalveinasararecauseofportopulmonaryhypertensionacasestudyseries
AT ivetasimkova congenitalabsenceoftheportalveinasararecauseofportopulmonaryhypertensionacasestudyseries